drugset / Trial / NCT07776665

A Clinical Trial of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-044)

NCT07776665 ↗

Phase 1 Active not recruiting 30 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of this trial is to learn what happens to different formulations (types) of enlicitide in a healthy person's body over time. Researchers will compare the amount of enlicitide in a healthy person's body over time when different formulations are given on an empty stomach and after a high-fat meal.

Timeline

Start
2026-08-31
Primary completion
2026-12-14
Completion
2026-12-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown — Oral

Indications

No indication recorded.